Analyst Reco. Docebo Inc.

Equities

DCBO

CA25609L1058

Market Closed - Toronto S.E. Other stock markets 21:00:00 14/05/2024 BST			5-day change	1st Jan Change
51.07 ^CAD	+3.11%		-20.56%	-20.19%

05-13	Needham Adjusts Price Target on Docebo to $45 From $63, Keeps Buy Rating	MT
05-10	National Bank Reviews Docebo's Q1 -- Trims Target to US$55	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Needham Adjusts Price Target on Docebo to $45 From $63, Keeps Buy Rating	05-13	MT
Morgan Stanley Trims Price Target on Docebo to $65 From $67, Keeps Overweight Rating	04-19	MT
Scotiabank Raises Docebo's Price Target to $65 From $60, Keeps Sector Outperform Rating	02-26	MT
Morgan Stanley Adjusts Price Target on Docebo to $67 From $63, Keeps Overweight Rating	02-26	MT
Morgan Stanley Boosts Price Target on Docebo to $63 From $53, Keeps Overweight Rating	12-22	MT
Docebo Maintained at Buy at Stifel GMP Following C-Suite Changes; Price Target Raised to US$60.00	11-23	MT
Needham Starts Docebo With Buy Rating, Price Target is $56	11-14	MT
Goldman Sachs Raises Price Target on Docebo to $44 From $39, Maintains Neutral Rating	11-10	MT
Morgan Stanley Adjusts Price Target on Docebo to $53 From $49, Keeps Overweight Rating	11-10	MT
Docebo Outperform Rating Reiterated by National Bank Following Q3 Results; Price Target Raised to US$60.00	11-09	MT
Morgan Stanley Upgrades Docebo to Overweight From Equalweight, Raises Price Target to $49 From $40	18/08/23	MT
Morgan Stanley Adjusts Price Target on Docebo to $40 From $37, Keeps Equalweight Rating	11/08/23	MT
Goldman Sachs Starts Docebo at Neutral With $37 Price Target	22/05/23	MT
Morgan Stanley Adjusts Price Target on Docebo to $37 From $39, Maintains Equalweight Rating	12/05/23	MT
Morgan Stanley Adjusts Price Target on Docebo to $39 From $36, Maintains Equalweight Rating	10/03/23	MT
Canaccord Genuity Adjusts Docebo Price Target to $50 From $40, Maintains Buy Rating	10/03/23	MT
National Bank Reiterates Rating, Target Price on Docebo; Sees Q4 Results, Outlook As Consistent with Investment Thesis	09/03/23	MT
Morgan Stanley Adjusts Price Target on Docebo to $36 From $40, Maintains Equalweight Rating	11/11/22	MT
Morgan Stanley Adjusts Price Target on Docebo to $44 From $41, Maintains Equalweight Rating	12/08/22	MT
Morgan Stanley Adjusts Docebo Price Target to $41 From $43, Maintains Equal Weight Rating	19/07/22	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Docebo Inc.

Equities

DCBO

CA25609L1058

Analyst Reco.

Filters